Notch transactivates Rheb to maintain the multipotency of TSC-null cells

Male 0301 basic medicine Lung Neoplasms Science Angiomyolipoma 610 Mice, Transgenic Mice, SCID Article Tuberous Sclerosis Complex 1 Protein 03 medical and health sciences Tuberous Sclerosis Tuberous Sclerosis Complex 2 Protein Animals Humans Lymphangioleiomyomatosis Receptor, Notch1 Promoter Regions, Genetic 0303 health sciences Tumor Suppressor Proteins Q Cell Differentiation Xenograft Model Antitumor Assays Neural Crest Transcription Factor HES-1 Female Ras Homolog Enriched in Brain Protein
DOI: 10.1038/s41467-017-01845-1 Publication Date: 2017-11-23T11:28:45Z
ABSTRACT
AbstractDifferentiation abnormalities are a hallmark of tuberous sclerosis complex (TSC) manifestations; however, the genesis of these abnormalities remains unclear. Here we report on mechanisms controlling the multi-lineage, early neuronal progenitor and neural stem-like cell characteristics of lymphangioleiomyomatosis (LAM) and angiomyolipoma cells. These mechanisms include the activation of a previously unreported Rheb-Notch-Rheb regulatory loop, in which the cyclic binding of Notch1 to the Notch-responsive elements (NREs) on the Rheb promoter is a key event. This binding induces the transactivation of Rheb. The identified NRE2 and NRE3 on the Rheb promoter are important to Notch-dependent promoter activity. Notch cooperates with Rheb to block cell differentiation via similar mechanisms in mouse models of TSC. Cell-specific loss of Tsc1 within nestin-expressing cells in adult mice leads to the formation of kidney cysts, renal intraepithelial neoplasia, and invasive papillary renal carcinoma.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (67)
CITATIONS (21)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....